These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2199446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.
    Pichuantes S, Babé LM, Barr PJ, Craik CS.
    Proteins; 1989; 6(3):324-37. PubMed ID: 2695931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG, Hui JO, Sawyer TK, Staples DJ, Bannow C, Reardon IM, Howe WJ, DeCamp DL, Craik CS, Heinrikson RL.
    J Biol Chem; 1990 Aug 25; 265(24):14675-83. PubMed ID: 2201691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
    Partin K, Kräusslich HG, Ehrlich L, Wimmer E, Carter C.
    J Virol; 1990 Aug 25; 64(8):3938-47. PubMed ID: 2196384
    [Abstract] [Full Text] [Related]

  • 7. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N, Heath W, Osborne E, Lai M, Vlahos C.
    Biochem Biophys Res Commun; 1990 Mar 16; 167(2):554-60. PubMed ID: 2182016
    [Abstract] [Full Text] [Related]

  • 8. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    Erickson-Viitanen S, Manfredi J, Viitanen P, Tribe DE, Tritch R, Hutchison CA, Loeb DD, Swanstrom R.
    AIDS Res Hum Retroviruses; 1989 Dec 16; 5(6):577-91. PubMed ID: 2692658
    [Abstract] [Full Text] [Related]

  • 9. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
    Tomasselli AG, Olsen MK, Hui JO, Staples DJ, Sawyer TK, Heinrikson RL, Tomich CS.
    Biochemistry; 1990 Jan 09; 29(1):264-9. PubMed ID: 2182116
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of HIV protease activity by heterodimer formation.
    Babé LM, Pichuantes S, Craik CS.
    Biochemistry; 1991 Jan 08; 30(1):106-11. PubMed ID: 1988010
    [Abstract] [Full Text] [Related]

  • 11. Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.
    Saiga A, Tanaka T, Orita S, Sato A, Sato S, Hachisu T, Abe K, Kimura Y, Kondo Y, Fujiwara T.
    Arch Virol; 1993 Jan 08; 128(3-4):195-210. PubMed ID: 8435041
    [Abstract] [Full Text] [Related]

  • 12. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.
    Daenke S, Schramm HJ, Bangham CR.
    J Gen Virol; 1994 Sep 08; 75 ( Pt 9)():2233-9. PubMed ID: 8077922
    [Abstract] [Full Text] [Related]

  • 13. Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.
    Darke PL, Leu CT, Davis LJ, Heimbach JC, Diehl RE, Hill WS, Dixon RA, Sigal IS.
    J Biol Chem; 1989 Feb 05; 264(4):2307-12. PubMed ID: 2644259
    [Abstract] [Full Text] [Related]

  • 14. Immunological characterization of the gag gene products of bovine immunodeficiency virus.
    Battles JK, Hu MY, Rasmussen L, Tobin GJ, Gonda MA.
    J Virol; 1992 Dec 05; 66(12):6868-77. PubMed ID: 1331499
    [Abstract] [Full Text] [Related]

  • 15. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
    Rosé JR, Salto R, Craik CS.
    J Biol Chem; 1993 Jun 05; 268(16):11939-45. PubMed ID: 8505318
    [Abstract] [Full Text] [Related]

  • 16. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG, Heinrikson RL.
    Methods Enzymol; 1994 Jun 05; 241():279-301. PubMed ID: 7854182
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
    Tözsér J, Bláha I, Copeland TD, Wondrak EM, Oroszlan S.
    FEBS Lett; 1991 Apr 09; 281(1-2):77-80. PubMed ID: 2015912
    [Abstract] [Full Text] [Related]

  • 18. Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.
    Babé LM, Rosé J, Craik CS.
    Protein Sci; 1992 Oct 09; 1(10):1244-53. PubMed ID: 1338945
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes.
    Patterson CE, Seetharam R, Kettner CA, Cheng YS.
    J Virol; 1992 Feb 09; 66(2):1228-31. PubMed ID: 1731102
    [Abstract] [Full Text] [Related]

  • 20. In vitro inhibition of HIV-1 proteinase by cerulenin.
    Moelling K, Schulze T, Knoop MT, Kay J, Jupp R, Nicolaou G, Pearl LH.
    FEBS Lett; 1990 Feb 26; 261(2):373-7. PubMed ID: 1690152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.